This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...